Press Releases

This memo is to inform North Carolina Immunization Program (NCIP) providers of the availability of influenza vaccine and the ordering process for the 2025-2026 respiratory season. Please take time to carefully review this memo in full.  

Dear Local Health Department Partner,

The purpose of this email is to remind VFC-enrolled providers that the monoclonal antibody product nirsevimab (trade name Beyfortus® manufactured by Sanofi) will be available for ordering on Friday, August 1, 2025.  

Download the RSV Vaccine Available for Ordering Memo

We are writing to inform you of several changes to the Vaccines for Children (VFC) program policies that may affect your practice, effective July 1, 2025.

This email is to inform you of an important update to share regarding measles reporting, testing, and vaccination.

In This Issue

• Message from the Chairman
• Certification Renewal Season is Here
• 2025 Jubilee
• Modern Well Drilling Industry Technology
• Online GW-1 Su

Dear Providers,

We’re excited to announce our Provider Lunch and Learn series, a new virtual educational offering from the North Carolina Immunization Program (NCIP).